Ecuador vs Liberia: Access to anti-retroviral drugs, male
Ecuador
87.0%
in 2024
Liberia
86.0%
in 2024
Ecuador rank
27th
Liberia rank
30th
Access to anti-retroviral drugs, male over time
- Ecuador
- Liberia
How they compare
Ecuador currently reports 87.0% against 86.0% in Liberia, a difference of 1.0%.
Across all 25 years both countries report, Ecuador has been ahead every year.
Ecuador ranks 27th and Liberia ranks 30th of 141 countries.
Ecuador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.2% | 2.0% | 3.2% | Ecuador |
| 2010s | 37.9% | 17.1% | 20.8% | Ecuador |
| 2020s | 79.8% | 63.2% | 16.6% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Ecuador or Liberia?
- Ecuador, at 87.0% against 86.0% in Liberia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Ecuador and Liberia?
- 1.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Liberia?
- 25 years are reported by both, from 2000 to 2024.
- How do Ecuador and Liberia rank globally for access to anti-retroviral drugs, male?
- Ecuador ranks 27th and Liberia ranks 30th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.